| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/05/2011 | CN101939318A Substituted piperidines as renin inhibitors |
| 01/05/2011 | CN101939317A Substituted aryloxazoles and the use thereof |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101939303A Novel crystalline forms |
| 01/05/2011 | CN101939291A Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 01/05/2011 | CN101939053A Soluble guanylate cyclase activators |
| 01/05/2011 | CN101939007A Protective effect of high dose folate on mycardial ischemia |
| 01/05/2011 | CN101939000A Materials and methods for treatment of pathological ocular vascular proliferation |
| 01/05/2011 | CN101935359A Liriope muscari baily polysaccharide and preparation method thereof |
| 01/05/2011 | CN101935358A Ganoderma lucidum polysaccharide and preparation method thereof |
| 01/05/2011 | CN101935351A Human vascuoar endothelial cell growth factor analogue |
| 01/05/2011 | CN101935349A Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/05/2011 | CN101935318A 2,3-dihydro-4(1H)- quinazolone derivative and application thereof |
| 01/05/2011 | CN101934078A Pharmaceutical composition comprising drospirenone and estrogen, and application thereof |
| 01/05/2011 | CN101934069A Application of neuroglobin in promoting neurite growth |
| 01/05/2011 | CN101934060A Medicament for treating hypertension |
| 01/05/2011 | CN101934037A Edaravone injection and preparation process thereof |
| 01/05/2011 | CN101934014A Nourishing type nutritional health-care wine |
| 01/05/2011 | CN101933972A Nitric oxide reinforcing agent and application thereof |
| 01/05/2011 | CN101933969A External ointment for treating hemorrhoid |
| 01/05/2011 | CN101933954A Medicinal composition |
| 01/05/2011 | CN101933945A Medicinal composition taking salidroside, D-ribose and honey as raw materials |
| 01/05/2011 | CN101933941A Protein-free pig blood extract water injection and preparation method thereof |
| 01/05/2011 | CN101933940A Application of pig blood deproteinized extract to cranial vascular disease |
| 01/05/2011 | CN101933934A Novel application of ginsenoside Rb1 |
| 01/05/2011 | CN101933926A Indolylmaleimde derivatives as PKC inhibitors |
| 01/05/2011 | CN101933924A A new use for deferiprone |
| 01/05/2011 | CN101933918A Sarpogrelate hydrochloride sustained-release preparation and preparation method |
| 01/05/2011 | CN101933915A Trans-dermal drug administration type Cilnidipine paster for treating hypertension and preparation method thereof |
| 01/05/2011 | CN101933905A Liposome composition for conveying eye treatment medicament |
| 01/05/2011 | CN101933899A Edaravone injection and preparation method thereof |
| 01/05/2011 | CN101647820B Active pure snake powder capsule and preparation technique thereof |
| 01/05/2011 | CN101584682B Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof |
| 01/05/2011 | CN101491492B Full aloe gelatin |
| 01/05/2011 | CN101362766B Extraction method for preparing high-purity allocryptopine |
| 01/05/2011 | CN101297954B Unbilical medicament for treating cough and preparation thereof |
| 01/05/2011 | CN101224226B Novel clinical uses of big nilgiri nettle |
| 01/05/2011 | CN101066253B Slow releasing ranolazine tablet |
| 01/05/2011 | CN101040907B Method of controlling the quality of salvia miltiorrhiza raw material fingerprint in the plant medicine for improving hemorheology |
| 01/04/2011 | US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/04/2011 | US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7863269 Imino-imidazo-pyridine derivatives having antithrombotic activity |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP) |
| 01/04/2011 | CA2640591C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2532631C Nasal pharmaceutical composition of piribedil |
| 01/04/2011 | CA2517707C Decreasing the incidence of atrial fibrillation (af) in patients with left ventricular dysfunction with ace inhibitors or angiotensin ii receptor antagonists |
| 01/04/2011 | CA2468039C Novel peptide having angiotensin converting enzyme inhibitory effect |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2451241C Unsymmetrical cyclic diamine compound |
| 01/04/2011 | CA2451238C Cyclic diamine compound with 5 membered ring groups |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2446828C Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2421228C Polyarylcarboxamides useful as lipid lowering agents |
| 01/04/2011 | CA2419423C Conjugates of peptides and peptide mimetics having integrin inhibitor properties |
| 01/04/2011 | CA2413426C Methods and compositions utilizing quinazolinones |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2389544C Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 01/04/2011 | CA2380370C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/04/2011 | CA2375008C Phenoxypropylamine compounds |
| 01/04/2011 | CA2306875C Nutritional supplement for cerebral metabolic insufficiencies |
| 01/04/2011 | CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 01/04/2011 | CA2304988C Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 12/30/2010 | US20100331999 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331746 Method of using enoxaparin for reducing the risk of death in acutely ill medical patients |
| 12/30/2010 | US20100331420 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331419 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331414 Crystal comprising (2r)-2-propyloctanoic acid and amine |
| 12/30/2010 | US20100331406 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/30/2010 | US20100331405 Methods of Treating Term and Near-Term Neonates Having Hypoxic Respiratory Failure Associated with Clinical or Echocardiographic Evidence of Pulmonary Hypertension |
| 12/30/2010 | US20100331399 Polyphenol extraction process |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331390 Effects of apolipoprotein b inhibition on gene expression profiles in animals |
| 12/30/2010 | US20100331386 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 12/30/2010 | US20100331384 Guanidine based compounds |
| 12/30/2010 | US20100331373 Drug-containing nanoparticles |
| 12/30/2010 | US20100331367 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 12/30/2010 | US20100331366 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 12/30/2010 | US20100331364 TREATMENT OF HFnEF |
| 12/30/2010 | US20100331363 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| 12/30/2010 | US20100331352 Novel crystalline forms of bosentan |
| 12/30/2010 | US20100331347 (en) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof |
| 12/30/2010 | US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 12/30/2010 | US20100331337 Quercetin-Containing Compositions |
| 12/30/2010 | US20100331336 Protective effect of high dose folate on mycardial ischemia |
| 12/30/2010 | US20100331333 Imidazo [1,2-B] Pyridazine Compounds |
| 12/30/2010 | US20100331322 Substituted piperidines as renin inhibitors |
| 12/30/2010 | US20100331317 Benzodiazepine compound and pharmaceutical composition |
| 12/30/2010 | US20100331315 Rhodanines and related heterocycles as kinase inhibitors |
| 12/30/2010 | US20100331314 Pyrazolopyrimidines and related heterocycles as kinase inhibitors |
| 12/30/2010 | US20100331313 Thiazole Derivatives as Protein Kinase Inhibitors |
| 12/30/2010 | US20100331309 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |
| 12/30/2010 | US20100331304 Compounds Which Modulate The CB2 Receptor |
| 12/30/2010 | US20100331298 Carboxamide Compounds and Their Use |
| 12/30/2010 | US20100331295 Modulators of lxr |